HLGEX | PMBCX | HLGEX / PMBCX | |
Total Expense Ratio | 0.84 | 1.75 | 48% |
Annual Report Gross Expense Ratio | 0.94 | 1.75 | 54% |
Fund Existence | 36 years | 18 years | - |
Gain YTD | 8.245 | 6.553 | 126% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.7B | 32.3B | 39% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 8.64 | 13.57 | 64% |
Returns for 3 years | 45.29 | 45.58 | 99% |
Returns for 5 years | 23.88 | 47.59 | 50% |
Returns for 10 years | 73.27 | 75.67 | 97% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GMF | 127.60 | 0.63 | +0.49% |
SPDR® S&P Emerging Asia Pacific ETF | |||
IGBH | 24.17 | 0.04 | +0.17% |
iShares Interest Rate Hdg L/T Corp BdETF | |||
EPP | 49.66 | 0.04 | +0.08% |
iShares MSCI Pacific ex Japan ETF | |||
FTXH | 26.31 | N/A | +0.01% |
First Trust Nasdaq Pharmaceuticals ETF | |||
FMCE | 26.35 | N/A | N/A |
FM Compounders Equity ETF |